Cargando…
Advances in circulating microRNAs as diagnostic and prognostic markers for ovarian cancer
Ovarian cancer is one of the most lethal malignant gynecological tumors. More than 70% of patients with ovarian cancer are diagnosed at advanced stage. The 5-year survival in patients with advanced ovarian cancer is less than 30% because of the lack of effective biomarkers for diagnosis, prognosis,...
Autores principales: | Zheng, Hong, Liu, Jia-Yu, Song, Feng-Ju, Chen, Ke-Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chinese Anti-Cancer Association
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3860338/ https://www.ncbi.nlm.nih.gov/pubmed/24379986 http://dx.doi.org/10.7497/j.issn.2095-3941.2013.03.001 |
Ejemplares similares
-
Circulating Plasma MicroRNAs As Diagnostic Markers for NSCLC
por: Hou, Jinpao, et al.
Publicado: (2016) -
Circulating microRNAs as Diagnostic Markers in Primary Aldosteronism
por: MacKenzie, Scott M., et al.
Publicado: (2021) -
Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers
por: Hamam, Rimi, et al.
Publicado: (2017) -
Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma
por: Jin, Yu, et al.
Publicado: (2019) -
Circulating microRNAs as the Potential Diagnostic and Prognostic Biomarkers for Nasopharyngeal Carcinoma
por: Le, Thuy Ai Huyen, et al.
Publicado: (2022)